Results 221 to 230 of about 35,541 (284)

nab-paclitaxel/carboplatin induction in squamous NSCLC: Longitudinal quality of life while on chemotherapy [PDF]

, 2017
et al,, Morgensztern, Daniel
core   +1 more source

The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 649-655, June 2026.
ABSTRACT Objective Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated to be an effective and well tolerated treatment for depression, and it is being investigated also for other indications. This study presents the Swedish National Quality Register for rTMS (Q‐rTMS).
S. Melker Hagsäter, Axel Nordenskjöld, Pia Nordanskog, Johan Lundberg, Carl Johan Ekman, Fredrik Hieronymus, Robert Bodén   +6 more
wiley   +1 more source

Health-related quality of life in patients on maintenance hemodialysis: Evidence from southern Iran using EQ-5D-5L and KDQOL-SF. [PDF]

PLoS One
Karami H, Mohammadi N, Shirvani Shiri M, Bordbar N, Mouseli A, Taheri Kondar R, Rezvani A, Vatankhah M.   +7 more
europepmc   +1 more source

How Can Community Paramedics Help in Addressing Mental Health for Vulnerable Australians?

Australian Journal of Rural Health, Volume 34, Issue 3, June 2026.
ABSTRACT Objectives Older adults in rural communities often have difficulty accessing mental healthcare. Community paramedicine may offer a novel opportunity to address this need. This study aimed to explore whether a feasibility trial of a community paramedicine programme, CP@clinic, can influence mental health outcomes in rural adults.
Laura Hemming, Ruth Hardman, Louise Reynolds, Renee Sharples, Gina Agarwal, Evelien Spelten   +5 more
wiley   +1 more source

Qualitative testing of the EQ-HWB-9 with a 'blank' EQ-HWB VAS and EQ-5D-5L with skin bolt-ons in a rare genetic skin disease population. [PDF]

Qual Life Res
Metyovinyi Z, Plázár D, Becker K, Medvecz M, Rencz F.   +4 more
europepmc   +1 more source

Patient‐reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial

BJU International, Volume 137, Issue 6, Page 1088-1096, June 2026.
Objective To compare the effects of percutaneous nephrostomy (PCN) and JJ ureteric stent (JJ) for urinary tract decompression in patients with obstructive urolithiasis on health‐related quality of life (HRQoL), pain scores, urinary symptoms, and patient satisfaction.
Hugo W. Schuil, Nora Hendriks, Ruben G. Duijnhoven, Bart C. H. Oskam, Tom J. H. Arends, Diederick Duijvesz, Alexander D. Horsch, Bart van der Heij, Irene M. Tjiam, Hans van Overhagen, Armand B. G. N. Lamers, Otto M. van Delden, Wout A. Scheepens, Jamie M. A. Drossaerts, Frank C. H. d'Ancona, Steven Boering, Janneke I. M. van Uhm, Rutger W. van der Meer, J. Herman van Roijen, Martin de Kiefte, Ad J.M. Hendrikx, Saskia Weltings, Rob C. M. Pelger, Harrie P. Beerlage, Barbara M. A. Schout, Guido M. Kamphuis   +25 more
wiley   +1 more source

Impact of Allergic Contact Dermatitis on Health‐Related Quality of Life: A Cross‐Sectional Case–Control Study in a Spanish Population

Contact Dermatitis, Volume 94, Issue 6, Page 592-602, June 2026.
Allergic contact dermatitis markedly impairs quality of life (QoL) across symptoms, functioning and emotional domains. Using DLQI, Skindex‐29 and EQ‐5D‐5L, our study demonstrates a substantial multidimensional burden and highlights the need for routine, patient‐centred QoL assessment in clinical management.
Francisco José Navarro‐Triviño, Álvaro Prados‐Carmona, Ricardo Ruiz‐Villaverde, María Isabel Peralta‐Ramírez   +3 more
wiley   +1 more source

Improving the value of population health data for health policy and decision-making using machine learning algorithms in EQ-5D-5L index estimation. [PDF]

Sci Rep
Hölgyesi Á, Zrubka Z, Neshat M, Jáger V, Kincses Á, Kovács L, Gulácsi L, Mirjalili S, Péntek M.   +8 more
europepmc   +1 more source

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed‐methods study

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aims Research and policy initiatives for type 1 diabetes (T1D) across European countries demonstrate an emergent, critical shift towards universal paediatric screening. National adaptations of screening, however, remain under‐researched. The current study, as part of the EU‐funded EDENT1FI programme, aimed to examine the psychosocial impact ...
O. Boiko, K. Barnard‐Kelly, J. Vercauteren, S. M. Greenfield, R. P. Dias, L. M. Quinn, I. Litchfield, T. Papanikolaou, J. L. Dunne, G. Perego, F. Gatti, F. Milano, B. M. Milazzo, V. Di Mattei, K. Lange, C. Mathieu, L. Overbergh, A.‐G. Ziegler, C. Hurtado Del Pozo, M. G. Scarale, A. Mahieu, A. J. Omar Alsaleh, E. Bosi, P. Narendran, on behalf of the EDENT1FI Consortium, C. Mathieu, P. Gillard, K. Casteels, B. van der Schueren, L. Overbergh, J. Vercauteren, A. G. Ziegler, P. Achenbach, F. Haupt, C. Winkler, S. Hummel, F. Reschke, O. Kordonouri, T. von dem Berge, K. Lange, T. Pieber, J. Mader, S. Moitzi, S. Del Prato, B. Torbeyns, Z. Sumnik, O. Cinek, V. Neuman, B. Berka, F. Pociot, B. Petersen, J. Antvorskov, J. H. Klaebel, R. Lahesmaa, H. Hyöty, J. E. Laiho, F. Reschke, O. Kordonouri, T. von dem Berge, E. Bonifacio, R. Berner, A. Hommel, A. Loff, G. Gemulla, N. Zubizarreta, E. Bosi, L. Piemonti, V. Lampasona, F. Dotta, G. Sebastiani, A. Szypowska, K. Karczewski, P. Jarosz‐Chobot, J. F. Raposo, R. Ribeiro, R. Coelho, M. Peakman, E. Niemoeller, M. Baccara‐Dinet, J. Van Rampelbergh, R. Bergholdt, K. Fogh, O. Cohen, M. I. Buompensiere, C. Hurtado del Pozo, E. Latres, G. Agiostratidou, A. Koralova, J. Jackson, D. Darrock, H. Tewson, S. Nagallas, J. Hedrick, K. Collins, T. Tree, C. Dayan, K. Hood, J. Townson, R. Playle, R. Besser, P. Narendran, I. Litchfield, S. Greenfield, R. Dias   +103 more
wiley   +1 more source

SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4602-4609, June 2026.
ABSTRACT Background Although semaglutide 2.4 mg has demonstrated significant weight loss efficacy in clinical trials, real‐world data, particularly with regard to clinically complex and underrepresented populations, remain limited. Objectives The study aims to assess the real‐world effectiveness and patient‐reported outcomes associated with the use of ...
Pierre Bel Lassen, David Jacobi, Marie‐Claude Brindisi, Jean‐Baptiste Bonnet, Fabien Subtil, Sylvie Bin, Fanny Abad, Christine Poitou, Bérénice Segrestin, Séverine Ledoux, Bénédicte Gaborit, Judith Aron‐Wisnewsky, Claire Carette, Mohamed Zerguine, Blandine Gatta‐Cherifi, Didier Quilliot, Emilie Montastier, Antoine Avignon, Héléna Mosbah, Sébastien Czernichow, Emmanuel Disse   +20 more
wiley   +1 more source